US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Novo Nordisk A/S B Shares ADRhedged

23.74

+0.79293.45%

Post-market: 23.770.0221+0.09%16:15 EDT

Volume:657

Turnover:15.43K

Market Cap:4.04M

PE:- -

High:23.77

Open:23.15

Low:23.15

Close:22.95

52wk High:34.36

52wk Low:19.00

Shares:170.00K

Float Shares:170.00K

Volume Ratio:0.97

T/O Rate:0.39%

Dividend:1.56

Dividend Rate:6.56%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Novo Nordisk announces STEP Young phase 3 trial met its primary endpoint

Novo Nordisk (NVO) Hit by Another Heart Drug Setback

Novo Nordisk A/S Series B Stock Flat Monday, Underperforms Market

Novo Nordisk Stock (NVO) Falls Despite Success in Children’s Weight-Loss Trial

Novo Nordisk's GLP-1 Drug Shows Promise in Reducing Childhood Obesity in Younger Kids

Novo Scraps Two More Heart Drug Trials, Further Dimming Growth Beyond Obesity

Clever Culture Systems Wins Expanded Novo Nordisk Order as APAS Nears Global Validation

Novo Nordisk Advances New Obesity Drug NNC0721-8060 Into First Human Trial

Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market

Sector Update: Healthcare

MT Newswires Live

Novo Nordisk Foundation to Set Up Quantum Chip Facility

MT Newswires Live

Surge in Crypto ETFs as Hawkish Fed Concerns Ease

Novo Nordisk A/S Series B Stock Rises Wednesday, Outperforms Market

European Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading

MT Newswires Live

Novo Nordisk A/S Stock (NVO) Moved Up by 3.17% on Sep 2: What Signal Does It Send?

Pharma Giant Novo Nordisk’s Stock (NVO) Jumps Even as Deutsche Bank Repeats Sell Call

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Novo Nordisk Launches Wegovy Weight-Loss Pill in Germany

New National Essential Medicines List Takes Effect September 1, Introducing Semaglutide Injection (Novotai) as a New Option for Primary Diabetes Management

1 Weight Loss Drugs Effective Even at Low Starter Doses

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/NVOH/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"NVOH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","market":"US","secType":"STK","nameCN":"Novo Nordisk A/S B Shares ADRhedged","latestPrice":23.7429,"timestamp":1789675200000,"preClose":22.95,"halted":0,"volume":657,"hourTrading":{"tag":"盘后","latestPrice":23.765,"preClose":23.7429,"latestTime":"16:15 EDT","volume":8,"amount":189.9432,"timestamp":1789676100260,"change":0.0221,"changeRate":0.000931,"amplitude":0},"delay":0,"changeRate":0.034549019607843116,"floatShares":170001,"shares":170001,"eps":0,"marketStatus":"Closed","change":0.7929,"latestTime":"09-17 16:00:00 EDT","open":23.15,"high":23.765,"low":23.15,"amount":15430,"amplitude":0.026797,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789718400000},"marketStatusCode":5,"adr":0,"exchange":"ARCA","adjPreClose":22.95,"nav":22.814512,"aum":3878489.854512,"dividendRate":0.065632,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":23.765,"preClose":23.7429,"latestTime":"16:15 EDT","volume":8,"amount":189.9432,"timestamp":1789676100260,"change":0.0221,"changeRate":0.000931,"amplitude":0},"volumeRatio":0.968741,"impliedVol":0.2452,"impliedVolPercentile":0.5812},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","floatShares":170001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.968741,"shares":170001,"dividePrice":1.5583,"high":23.765,"amplitude":0.026797,"preClose":22.95,"low":23.15,"week52Low":19,"pbRate":"--","week52High":34.36,"institutionHeld":0,"latestPrice":23.7429,"eps":0,"divideRate":0.065632,"volume":657,"delay":0,"ttmEps":0,"open":23.15,"prevYearClose":27.4362,"prevWeekClose":23.4261,"prevMonthClose":24.5859,"prevQuarterClose":26.0576,"fiveDayClose":23.954,"twentyDayClose":25.0553,"sixtyDayClose":25.8826},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVOH\",params:#limit:5,,,undefined,":[{"date":"2026-09-16","symbol":"NVOH","amount":0.02979,"announcedDate":"2026-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-16","defaultRemindTime":1789565400000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-23","payableDate":"2026-09-16","currency":"USD","dateTimestamp":1789531200000,"payDate":"2026-09-23"},{"date":"2026-06-16","symbol":"NVOH","amount":0.76666,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"NVOH","amount":0.27495,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"NVOH","amount":0.48798,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"},{"date":"2025-09-16","symbol":"NVOH","amount":0.16566,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"Novo Nordisk A/S (B Shares) ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-23","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVOH\",market:\"US\",,,undefined,":[{"executeDate":"2025-09-16","recordDate":"2025-09-16","paymentDate":"2025-09-23","value":0.16566,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.48798,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.27495,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.76666,"currency":"USD"},{"executeDate":"2026-09-16","recordDate":"2026-09-16","paymentDate":"2026-09-23","value":0.02979,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVOH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVOH\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665109773","title":"Novo Nordisk announces STEP Young phase 3 trial met its primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2665109773","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665109773?lang=en_us&edition=fundamental","pubTime":"2026-09-08 02:10","pubTimestamp":1788804610,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO) announced first results from the STEP Young phase 3 trial, evaluating once-weekly semaglutide in combination with a reduced-calo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-announces-step-young-phase-3-trial-met-its-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-announces-step-young-phase-3-trial-met-its-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","BK4532","BK4588","LU0154236417.USD","BK4007","NVOX","LU1093756325.SGD","IE00BKVL7J92.USD","NVOH","IE00BZ1G4Q59.USD","PPH","NVOC","BK4585","THNR","OZEM","LU1093756168.USD","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665862310","title":"Novo Nordisk (NVO) Hit by Another Heart Drug Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2665862310","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665862310?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:56","pubTimestamp":1788800218,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) has halted two late‑stage studies of its experimental heart drug ziltivekimab, marking a major setback in its push into cardiov...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/novo-nordisk-nvo-hit-by-another-heart-drug-setback?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/novo-nordisk-nvo-hit-by-another-heart-drug-setback?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BZ1G4Q59.USD","BK4007","BK4588","IE00BKVL7J92.USD","LU0154236417.USD","LU1093756325.SGD","NVO","NVOX","OZEM","THNR","PPH","NVOH","BK4599","BK4532","NVOC","BK4585","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665731749","title":"Novo Nordisk A/S Series B Stock Flat Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2665731749","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665731749?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:02","pubTimestamp":1788796920,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B were flat  at DKK298.95 Monday on what proved to be an overall positive trading session for the stock market, with the OMX Nordic 40 Index rising 0.3% to 2,710.84.The stock's rise  snapped a two-day losing streak.The company closed DKK111.00 short of its 52-week high of DKK409.95, which the company reached on January 23, 2026.Trading volume was 1,797,150, compared to the 50-day average trading volume of 4,122,224.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","NVO","OZEM","BK4007","BK4532","IE00BKVL7J92.USD","NVOX","NVOC","BK4585","NVOH","BK4588","LU0154236417.USD","LU1093756325.SGD","PPH","BK4599","IE00BZ1G4Q59.USD","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665131175","title":"Novo Nordisk Stock (NVO) Falls Despite Success in Children’s Weight-Loss Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665131175","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665131175?lang=en_us&edition=fundamental","pubTime":"2026-09-07 20:32","pubTimestamp":1788784376,"startTime":"0","endTime":"0","summary":"Novo Nordisk’s ($NVO) shares in Copenhagen edged lower on Monday afternoon. This came even after the Danish pharma giant said in a statement that i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/novo-nordisk-stock-nvo-falls-despite-success-in-childrens-weight-loss-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/novo-nordisk-stock-nvo-falls-despite-success-in-childrens-weight-loss-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1093756168.USD","NVOC","LU0154236417.USD","NVOH","NVOX","OZEM","IE00BKVL7J92.USD","BK4599","PPH","BK4585","LU1093756325.SGD","BK4588","IE00BZ1G4Q59.USD","THNR","BK4532","NVO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185411766","title":"Novo Nordisk's GLP-1 Drug Shows Promise in Reducing Childhood Obesity in Younger Kids","url":"https://stock-news.laohu8.com/highlight/detail?id=1185411766","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185411766?lang=en_us&edition=fundamental","pubTime":"2026-09-07 20:20","pubTimestamp":1788783624,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO.US) announced on Monday that in a late-stage clinical trial, its blockbuster weight-loss drug Wegovy's active ingredient, semaglutide, helped 40.4% of children aged 6 to under 12...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THNR","PINK","CURE","NVOC","NVOH","MEDI","RSPH","BGIA","NVOX","NBDS","FHLC","TRUH","XLVI","FXH","IYH","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665319474","title":"Novo Scraps Two More Heart Drug Trials, Further Dimming Growth Beyond Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2665319474","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665319474?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:42","pubTimestamp":1788781356,"startTime":"0","endTime":"0","summary":"Novo scraps two more heart drug trials, further dimming growth beyond obesitySept 7 (Reuters)-Novo NordiskNOVOb.COsaid on Monday it had halted two additional trials of its experimental cardiovascular ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nL6N44Z0K2:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Novo Scraps Two More Heart Drug Trials, Further Dimming Growth Beyond Obesity","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOH","NVOX","NVOC","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665398326","title":"Clever Culture Systems Wins Expanded Novo Nordisk Order as APAS Nears Global Validation","url":"https://stock-news.laohu8.com/highlight/detail?id=2665398326","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665398326?lang=en_us&edition=fundamental","pubTime":"2026-09-07 08:23","pubTimestamp":1788740626,"startTime":"0","endTime":"0","summary":"The latest update is out from LBT Innovations Limited ( ($AU:CC5) ). Clever Culture Systems Ltd, an Adelaide-based specialist in AI microbiology au...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/clever-culture-systems-wins-expanded-novo-nordisk-order-as-apas-nears-global-validation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/clever-culture-systems-wins-expanded-novo-nordisk-order-as-apas-nears-global-validation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BKVL7J92.USD","THNR","BK4599","NVOC","BK4532","CC5.AU","BK7007","LU1093756325.SGD","NVOX","OZEM","NVO","PPH","IE00BZ1G4Q59.USD","LU0154236417.USD","LU1093756168.USD","BK4585","BK4007","NVOH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665835320","title":"Novo Nordisk Advances New Obesity Drug NNC0721-8060 Into First Human Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665835320","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665835320?lang=en_us&edition=fundamental","pubTime":"2026-09-05 00:31","pubTimestamp":1788539471,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) announced an update on their ongoing clinical study. The study A Study Investigating Safety, Tolerability, Pharmacokinetics and...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-advances-new-obesity-drug-nnc0721-8060-into-first-human-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-advances-new-obesity-drug-nnc0721-8060-into-first-human-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU1093756168.USD","NVO","BK4599","THNR","LU0154236417.USD","NVOH","BK4007","BK4532","PPH","NVOC","IE00BKVL7J92.USD","LU1093756325.SGD","BK4585","NVOX","IE00BZ1G4Q59.USD","OZEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665353356","title":"Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2665353356","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665353356?lang=en_us&edition=fundamental","pubTime":"2026-09-05 00:02","pubTimestamp":1788537720,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B dropped 0.9% to DKK298.90 Friday on what proved to be an overall mediocre trading session for the stock market, with the OMX Nordic 40 Index holding steady at 2,702.17.This was the stock's second consecutive day of losses.The company closed DKK111.05 short of its 52-week high of DKK409.95, which the company achieved on January 23, 2026.Trading volume was 3,129,002, compared to the 50-day average trading volume of 4,174,340.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPH","BK4599","IE00BZ1G4Q59.USD","NVO","IE00BKVL7J92.USD","BK4532","BK4585","LU1093756325.SGD","NVOH","THNR","LU1093756168.USD","LU0154236417.USD","BK4007","NVOC","OZEM","NVOX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664533403","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2664533403","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664533403?lang=en_us&edition=fundamental","pubTime":"2026-09-04 21:00","pubTimestamp":1788526844,"startTime":"0","endTime":"0","summary":"Healthcare stocks were declining pre-bell Friday, with the State Street Health Care Select Sector SPDR ETF  down 0.3% and the iShares Biotechnology ETF  0.2% lower.Novo Nordisk's  charitable foundation and its Quantum Foundry Copenhagen company are planning to set up a new 5,300 square meter quantum chip production facility in Copenhagen, the organizations said. Shares of Novo Nordisk were down more than 1% premarket.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IBB","OZEM","BK4581","THNR","PPH","XLV","BK4532","IE00BKVL7J92.USD","NVOX","BK4588","LU1093756325.SGD","LU1093756168.USD","IE00BZ1G4Q59.USD","BK4007","NVOH","XBI","LU0154236417.USD","NVOC","LABU","BK4585","BK4599","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664874873","title":"Novo Nordisk Foundation to Set Up Quantum Chip Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2664874873","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664874873?lang=en_us&edition=fundamental","pubTime":"2026-09-04 16:10","pubTimestamp":1788509441,"startTime":"0","endTime":"0","summary":"Novo Nordisk's  charitable foundation and its Quantum Foundry Copenhagen company are planning to set up a new 5,300 square meter quantum chip production facility in Copenhagen, the organizations said Friday.The new plant aims to develop manufacturing equipment for the production of quantum chips.The facility will include laboratory space for nano-fabrication of quantum materials, testing, chip assembly and packaging, along with vacuum manufacturing capabilities, offering wafer fabrication services for customers worldwide, the organizations said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0154236417.USD","BK4585","IE00BKVL7J92.USD","BK4532","BK4007","LU1093756168.USD","NVOC","LU1093756325.SGD","IE00BZ1G4Q59.USD","BK4599","NVOH","OZEM","PPH","BK4588","THNR","NVOX","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139354085","title":"Surge in Crypto ETFs as Hawkish Fed Concerns Ease","url":"https://stock-news.laohu8.com/highlight/detail?id=1139354085","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139354085?lang=en_us&edition=fundamental","pubTime":"2026-09-04 14:03","pubTimestamp":1788501803,"startTime":"0","endTime":"0","summary":"Cryptocurrency-linked exchange-traded funds listed in Hong Kong posted sharp gains on Tuesday, tracking a broad rally in digital assets after dovish comments from a Federal Reserve official dampened...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBIL","BK4082","EZBC","RGTC","COIO","LITC","MAXI","DAPP","HODL","BTRN","BITQ","BK4112","ETTY","SPDN","BK4516","COII","LU1861220207.SGD","MNRS","RGYY","BLOK","SH","COZX","CBTO","07711","BAGY","BETE","BTC","SSO","ICOI","DFII","CBTJ","NCIQ","07799","VRTL","ETNG","SAA","LU1861559042.SGD","COIN","IVV","CBOJ","LITG","BITW","BTCW","09711","FIAT","SPUU","RGTU","VRC","NBIC","COIA","GBTC","LU2360107671.USD","BLCK","NVOC","TEKX","BK4535","VOO","BITO","BETH","BFJL","SPYM","BK4595","CBXJ","CONX","BK4585","BK4588","FINX","LABX","HECO","NVTC","FBTC","BITU","IBIT","CRPT","IBLC","NBIG","TEUP","YSPY","ONTX","BTCC","QBF","NBIZ","BITB","BTCO","COIG","SPYH","XBTY","BITY","LFGY","YBTC","CBOY","BPI","CONL","BK4601","BITI","SPXS","SPXU","STCE","CBTA","CBTY","MMAX","07311","BK4007","BTF","BFAP","DEFI","GDLC","HIBL","NVTX","NVOH","RGTZ","BK4594","07399","BK4551","FDN","BLOX","SPY","BTCI","LITZ","BRRR","DIME","SDS","BK4600","CONI","BKCH","CONY","LU1861217088.USD","LITU","SMAX","COIX","SPYU","NVOX","BCCC","BTCZ","BTCL","LU1861558580.USD","SPYQ","BK4596","CBOO","UPRO","OSSL","BITX","NEBX","LITX","BK4554","ARKB","CBOA","TXXH","CBXA","COIW","CBXO","COYY","FDIG","DMAX","CRY","09311","CBXY","MVV","BK4539","RGTX","SBIT","BK4550","XW","SPXL","SIMX","ALA","GCPU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664848475","title":"Novo Nordisk A/S Series B Stock Rises Wednesday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2664848475","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664848475?lang=en_us&edition=fundamental","pubTime":"2026-09-03 00:02","pubTimestamp":1788364920,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B advanced 2.6% to DKK301.65 Wednesday on what proved to be an overall unfavorable trading session for the stock market, with the OMX Nordic 40 Index falling 0.3% to 2,678.58.This was the stock's second consecutive day of gains.The company closed DKK108.30 below its 52-week high of DKK409.95, which the company reached on January 23, 2026.Trading volume was 4,095,568, compared to the 50-day average trading volume of 4,185,751.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO","BK4532","LU0154236417.USD","BK4585","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4007","OZEM","THNR","NVOX","NVOC","BK4588","NVOH","PPH","LU1093756325.SGD","BK4599","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664081008","title":"European Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2664081008","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664081008?lang=en_us&edition=fundamental","pubTime":"2026-09-02 23:13","pubTimestamp":1788362021,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending higher late Wednesday morning, rising 0.50% to 1,960.43 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm Evaxion  and semiconductor company Sequans Communications , which rose 4% and 3.6% respectively. They were followed by pharmaceutical company Novo Nordisk  and lender ING Group , which were up 3.5% and 2.9% respectively.The decliners from continental Europe were led by internet browser company Opera  and petroleum refiner Equinor , which dropped  2.3% and 1.5% respectively. They were followed by telecommunications companies Nokia  and Ericsson , which lost 0.8% and 0.7% respectively.The gainers from the UK were led by hospitality company InterContinental Hotels Group  and biopharmaceutical company Bicycle Therapeutics , which advanced 4.1% and 3.1% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals  and mining company BHP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BMPRXR70.SGD","NVOH","LFGY","TRIB","NVOX","EQNR","IHG","LU1093756325.SGD","BK4082","BK4204","IE00BMPRXN33.USD","NVO","IE00BZ1G4Q59.USD","BK4020","BK4141","BK4207","SQNS","BK4547","LNOK","BK4007","NVOC","OZEM","THNR","SLX","BDRX","BK4009","PSO","BK4599","BK4168","BK4554","LU1093756168.USD","ERIC","BK4023","BHP","BK4515","BK4111","LU0300736492.USD","LU0154236417.USD","EVAX","BK4532","BK4505","ING","BK4139","BK4201","BK4585","BK4588","NOK","BK4591","IE00BKVL7J92.USD","PPH","BCYC","MREO","COAL","LU0300736062.USD","WPP","LU0006061336.USD","OPRA","BK4142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664037817","title":"Novo Nordisk A/S Stock (NVO) Moved Up by 3.17% on Sep 2: What Signal Does It Send?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664037817","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664037817?lang=en_us&edition=fundamental","pubTime":"2026-09-02 22:15","pubTimestamp":1788358521,"startTime":"0","endTime":"0","summary":"• Novo Nordisk launched its oral weight-loss treatment in Germany and Greater China.\n• The company continues executing its multi-billion share repurchase program supporting shareholders.\n• Annual revenue reached $46.70B with net profit totaling $15.48B.","market":"nz","thumbnail":"https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262146652-market-movers-nvo-20260902","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","BK4532","BK4588","LU0154236417.USD","BK4007","NVOX","LU1093756325.SGD","IE00BKVL7J92.USD","NVOH","IE00BZ1G4Q59.USD","PPH","NVOC","BK4585","THNR","OZEM","LU1093756168.USD","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664178118","title":"Pharma Giant Novo Nordisk’s Stock (NVO) Jumps Even as Deutsche Bank Repeats Sell Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2664178118","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664178118?lang=en_us&edition=fundamental","pubTime":"2026-09-02 21:59","pubTimestamp":1788357575,"startTime":"0","endTime":"0","summary":"Shares of Novo Nordisk ($NVO) climbed by 4% to about $47 per share on Wednesday morning even after Deutsche Bank ($DB) reaffirmed its Sell rating o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/pharma-giant-novo-nordisks-stock-nvo-jumps-even-as-deutsche-bank-repeats-sell-call?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/pharma-giant-novo-nordisks-stock-nvo-jumps-even-as-deutsche-bank-repeats-sell-call?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0154236417.USD","NVOX","THNR","LU1093756325.SGD","OZEM","LU1093756168.USD","BK4599","NVOH","BK4588","BK4532","BK4585","IE00BKVL7J92.USD","PPH","BK4007","NVO","NVOC","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664568448","title":"Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2664568448","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664568448?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:49","pubTimestamp":1788263354,"startTime":"0","endTime":"0","summary":"FACTBOX-Global pharma companies that have publicly announced Trump drug pricing agreementsSept 1 (Reuters)-U.S. President Donald Trump has struck drug-pricing deals with more than 20 pharmaceutical co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4N44T0TS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242646821.SGD","SG9999015978.USD","LU1934455277.USD","LU2487616109.SGD","BK7067","LU1267930813.SGD","LU1804176565.USD","IE000WAW04H5.SGD","AZN","LU1201861249.SGD","LU2756315318.SGD","LU0965509010.AUD","LU2896262040.SGD","IE00B4JS1V06.HKD","LU2125909247.SGD","LU1037948897.HKD","LU2237443382.USD","LU0070217475.USD","LU1691799644.USD","LU0545562505.USD","LU1571399168.USD","LU0211331839.USD","BK4592","LU1868837300.USD","LU2592432038.USD","LU0320765992.SGD","LU0109394709.USD","LU2361044949.HKD","LU1989772840.SGD","BIB","BK4550","IE00BLSP4239.USD","LU2362541513.USD","LU0511384066.AUD","LU1291159041.SGD","SG9999001176.SGD","LU2129689605.HKD","LU2265009873.SGD","AZNH","SG9999014906.USD","LU0058720904.USD","LU2468319806.SGD","LU0070302665.USD","CANC","SG9999003800.SGD","IE00B2B36J28.USD","LU2213496289.HKD","IE000MB6IJN5.SGD","ABBV","LU0158827948.USD","LU0823434583.USD","LU0237698245.USD","IE0001KFT4U8.USD","LU1323610961.USD","LU2125154778.USD","LU1093756168.USD","PBE","LU1236620750.USD","LU1941712264.USD","LU1551013425.SGD","LU2505996509.AUD","SG9999014880.SGD","LU0882574055.USD","TMED","LU0689472784.USD","IE0034235303.USD","LU2129689431.USD","NVOC","NVOX","LU0170899867.USD","BK4585","LU1914381329.SGD","LU2746668974.SGD","ONC","LU1023059063.AUD","LU0949170772.SGD","LU0097036916.USD","LU1720051017.SGD","GB00BDT5M118.USD","LU0994945656.USD","SGXZ57979304.SGD","LU0385154629.USD","LU1720051108.HKD","TRUH","SGXZ31699556.SGD","LU2133065610.SGD","BK7511","LU0306806265.USD","LU0471298694.HKD","LU0432979614.USD","688235","IE00BFSS8Q28.SGD","IE0002141913.USD","LU2089283258.USD","IE00B1BXHZ80.USD","IE00B3PB1722.GBP","PJP","LU2430703178.SGD","LU0069063385.USD","IE000F7OJYX1.SGD","VHT","LU2750360997.AUD","BK4505","LU0683600562.USD","OZEM","04332","LU0345770993.USD","THNR","LU2125909593.SGD","LU2491050071.SGD","LU1032955483.USD","IE00BGHQF631.EUR","XLV","LU0354030511.USD","LU1941712348.USD","LU1829250122.USD","PFE","SG9999014898.SGD","IBB","LU0057025933.USD","SG9999014914.USD","LU0211328371.USD","LU2433249047.HKD","LU0353189763.USD","LU1979441026.SGD","IE00BVYPNW00.USD","LU1670627923.USD","IE0004445015.USD","LU0786609619.USD","IE00BZ1G4Q59.USD","TBXU","IE0004445239.USD","BMY","SG9999015952.SGD","LU0787776722.HKD","LU2237438978.USD","LU2063271972.USD","LU2552382132.HKD","LU1551013342.USD","LU1839511570.USD","IE000BZT7R73.USD","IE00B7SZLL34.SGD","SGXZ99366536.SGD","LU2108987350.USD","LU1974910355.USD","LU2324357040.USD","SGXZ81514606.USD","SG9999014575.USD","IE00B19Z3B42.SGD","IE000M9KFDE8.USD","BK4583","LU0353189680.USD","LU0133085943.USD","SG9999014542.SGD","IE00BJLML261.HKD","IE00BSNM7G36.USD","BK0239","LU2271345857.HKD","LLYZ","LU2361045086.USD","LU0256863811.USD","IE00B775H168.HKD","LU0477156953.USD","LU1064131342.USD","LU1066051811.HKD","LU1221951046.USD","LU1623119135.USD","LU2264538146.SGD","LU2087621335.USD","BK4532","LU1267930730.SGD","LU0943347566.SGD","LU0738911758.USD","SG9999014559.SGD","LU2357305700.SGD","LU2089284900.SGD","LU0203201768.USD","LU1366192091.USD","LU1236620834.HKD","GILD","LU0310800379.SGD","LU1059921491.USD","LU0320765646.SGD","LU0234570918.USD","IE00BLSP4452.SGD","LU1929549753.HKD","LU0859254822.USD","LU1145028129.USD","LU1127390331.HKD","LU1868836591.USD","BK4566","BK4559","IE00BFTCPJ56.SGD","LU0198837287.USD","LU2023250843.SGD","BK4533","LU0985320562.USD","SG9999015945.SGD","LU0965509101.SGD","LU2491050154.USD","LU1917777945.USD","LU1778281490.HKD","LU2023251221.USD","LU2596442595.SGD","LU1732799900.SGD","RXL","BBH","PPH","IE00BVYPNV92.GBP","LU2362540622.SGD","LU2430703251.USD","BK4534","LU2456880835.USD","LU0912757837.SGD","SGXZ80539844.SGD","LU1506573853.SGD","LU0210528500.USD","PAWZ","LU0861579265.USD","LU2471134796.USD","LU2505996681.GBP","IE00BJJMRZ35.SGD","LU2471134952.CNY","LU0456855351.SGD","LU0882574139.USD","LU0154236417.USD","LU2237443895.HKD","LU2125154935.USD","LLYX","LU0265550946.USD","LU1670710661.SGD","LU0094547139.USD","LU0795875169.SGD","IE00B42XCP33.USD","LU2746668461.USD","LU0426412945.USD","LU2211815571.USD","LU2089984988.USD","LU1496350171.SGD","LU0114720955.EUR","LU1244550221.USD","AMGN","LU0053666078.USD","LLY","LU1934455194.USD","IE00B4R5TH58.HKD","LU0208291251.USD","LU2471134523.USD","LU0203345920.USD","LU1883839398.USD","SG9999015341.SGD","LU2023250504.SGD","LU1043141396.HKD","CURE","LU0238689110.USD","LU2112291526.USD","WDNA","IE0002270589.USD","LU1066053197.SGD","IE0000B7K699.USD","CSL.AU","IBBQ","LU0553294199.USD","LU0726765562.USD","LU0545039389.USD","BBIO","GSK.UK","LU1935042991.SGD","LU1116320901.HKD","LU1868837136.USD","LU0980610538.SGD","LU0708994859.HKD","IE00BFSS7M15.SGD","LU0661504455.SGD","LU0417517546.SGD","FTXH","LU0320765059.SGD","MEDX","LU0289739343.SGD","IE00BDGV0183.EUR","LU2462157665.USD","LU2357627491.SGD","LU0889566641.SGD","LU1699723380.USD","LU0471298777.SGD","LU0128525929.USD","LU1674673691.USD","GLAM","LU2362541273.HKD","LU1670711123.USD","HRTS","IE00B7KXQ091.USD","LU0106261372.USD","LU1670711040.USD","LU0472753341.HKD","SG9999001440.SGD","IE00BFXG1179.USD","LU1989772923.USD","LU0316494557.USD","LU2237443978.SGD","LU1280957306.USD","SG9999018857.SGD","IE00BN29S564.USD","LU1221951129.SGD","LU1162221912.USD","06160","IXJ","IE00BKDWB100.SGD","LU1121112475.USD","LU0689626769.HKD","SG9999001176.USD","BK7508","LU0267386448.USD","AGNG","LU0985481810.HKD","IE00BKPKM429.USD","LU1934455863.HKD","LU0823434740.USD","LU2236285917.USD","LU1430594728.SGD","LU1267930490.SGD","LU1066051225.USD","LU2750360641.GBP","LU1712237335.SGD","JNJ","LU1032466523.USD","LU1035775433.USD","LU1988902786.USD","LU2087625088.SGD","LU0130517989.USD","LU1894683264.USD","LU0225771236.USD","LU2403377893.USD","IE0009355771.USD","LU2360106947.USD","LU2028103732.USD","LU0158827781.USD","BK4599","IE00BK4W5L77.USD","LU1989771016.USD","LU2552382215.SGD","BK4568","LU2168564149.EUR","LU2417539215.USD","LU0708995401.HKD","NVS","MRK","IYH","IE00BJT1NW94.SGD","SG9999014567.USD","LU1003077747.HKD","LU1629891620.HKD","LU2462591350.SGD","LU2168564495.EUR","LU1035773651.USD","ELIL","LU1228905540.USD","MEDI","LU0345769631.USD","LU0203347892.USD","SG9999011175.SGD","LU0266013472.USD","SG9999018865.SGD","LU0124676726.USD","BK7501","LU0211327993.USD","SG9999015986.USD","LU0225284248.USD","LU0640476718.USD","SG9999017495.SGD","LU0130102774.USD","LU2461242641.AUD","LU0109391861.USD","LU0265550359.USD","LU0234572021.USD","LU0426417589.USD","LU0321505439.SGD","LU0162691827.USD","SG9999015358.SGD","IE00BJJMRX11.SGD","LU1267930573.SGD","LU2237443622.USD","LU1093756325.SGD","LU0792757196.USD","LU2552382058.USD","LU0965509283.SGD","LU0889565916.HKD","LU0320765489.SGD","ILDR","LU2602419157.SGD","LU1983299246.USD","LU1037948541.HKD","LU0203202063.USD","MHIP","LU2129689514.USD","LU0820561818.USD","LU2360032135.SGD","REGN","LU1261432733.SGD","LU0289739699.SGD","IE00B3T34201.USD","LU1894683348.USD","LU0345769128.USD","LU1232071149.USD","GSKH","LU2347655073.USD","IE00B19Z3581.USD","LU0072461881.USD","LU2237443549.SGD","NVOH","LU1732800096.USD","LU0354030438.USD","GDOC","LU1585245621.USD","LLII","LU0795875086.SGD","LU0868494708.USD","IE00BN8TJ469.HKD","LU0310799852.SGD","LU0942090050.USD","LU0289961442.SGD","LU1244550494.USD","LU0225283273.USD","LU1069344957.HKD","SGXZ51526630.SGD","LU1814569148.SGD","LU0029864427.USD","LU1718418525.SGD","BK4516","IE00B1XK9C88.USD","LU0466842654.USD","LU0345770308.USD","LU0868494617.USD","LU1496350502.SGD","LU2756315664.SGD","LU0323591593.USD","IE00BK4W5M84.HKD","IE00BBT3K403.USD","IE00BJJMRY28.SGD","NVO","LU1670710588.SGD","LU2491049909.HKD","LU1057294990.SGD","LU0648001328.SGD","LU1066051498.USD","SG9999002232.USD","JDOC","LU0672654240.SGD","LU1043141123.HKD","SG9999002224.SGD","IE000SO60NU8.SGD","BK4504","BMED","LU1074936037.SGD","LU0823416689.USD","LU1670628061.USD","LU1548497426.USD","LU0079474960.USD","LU2471134879.HKD","LU1228905037.USD","LU1674673428.USD","LU0006306889.USD","GSK","LU2111349929.HKD","LU0820562030.AUD","LU0306807586.USD","LU2168563687.JPY","IHE","LU2237443465.HKD","LU0964807845.USD","LU0098860793.USD","LU1244550577.SGD","LU0061475181.USD","LU0096364046.USD","LU2430703095.HKD","ELIS","BK4578","IE00BKVL7J92.USD","LU2347655156.SGD","LU0256863902.USD","LU1923622614.USD","LU2023250330.USD","LU0210536198.USD","BK4007","FHLC","LU1061106388.HKD","LU1868836914.USD","LU0174119429.USD","LU2361044865.SGD","IE0005OL40V9.USD","LU1069347547.HKD","IE00BWXC8680.SGD","LU0122379950.USD","SG9999013999.USD","BK4139","LU1868836757.USD","LU2168564222.USD","BK4588","LU0321505868.SGD","LU0820561909.HKD","LU1196500208.SGD","LU0965508806.USD","LU2242652126.USD","BK4581","LU1116320737.USD","LU0395794307.EUR","LU2168564065.EUR","LU2106854487.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664832960","title":"Novo Nordisk Launches Wegovy Weight-Loss Pill in Germany","url":"https://stock-news.laohu8.com/highlight/detail?id=2664832960","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664832960?lang=en_us&edition=fundamental","pubTime":"2026-09-01 16:54","pubTimestamp":1788252851,"startTime":"0","endTime":"0","summary":"Novo Nordisk launches Wegovy weight-loss pill in GermanyCOPENHAGEN, Sep 1 (Reuters)-Novo NordiskNOVOb.COhas launched its Wegovy pill in Germany, a spokesperson for the Danish drugmaker said on Tuesday","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL8N44L0T7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","NVOH","NVOX","OZEM","BK4007","NVO","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4588","LU0154236417.USD","LU1093756168.USD","PPH","THNR","BK4532","NVOC","BK4585","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184177715","title":"New National Essential Medicines List Takes Effect September 1, Introducing Semaglutide Injection (Novotai) as a New Option for Primary Diabetes Management","url":"https://stock-news.laohu8.com/highlight/detail?id=1184177715","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184177715?lang=en_us&edition=fundamental","pubTime":"2026-09-01 15:52","pubTimestamp":1788249152,"startTime":"0","endTime":"0","summary":"Effective September 1, the updated 2026 edition of China's National Essential Medicines List is officially in force, marking a significant milestone as the first major revision since 2018. Among the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OZEM","PPH","BK4007","IE00BKVL7J92.USD","JDOC","LU1093756325.SGD","BK4532","THNR","BK4599","BK4588","LU1093756168.USD","NVOC","NVOH","LU0154236417.USD","NVO","BK4585","NVOX","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664885722","title":"1 Weight Loss Drugs Effective Even at Low Starter Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=2664885722","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664885722?lang=en_us&edition=fundamental","pubTime":"2026-09-01 06:23","pubTimestamp":1788215012,"startTime":"0","endTime":"0","summary":"GLP-1 weight loss drugs effective even at low starter dosesAug 31 (Reuters)-People taking popular GLP-1 obesity drugs who remain on low starter doses will lose some weight but may still experience sid","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S0RO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B1XK9C88.USD","LU0133085943.USD","IHE","SGXZ51526630.SGD","LU2063271972.USD","LU1061106388.HKD","XLV","FTXH","CANC","LU1629891620.HKD","IYH","LU1127390331.HKD","LU0889565916.HKD","ILDR","LU1989771016.USD","LU2023250330.USD","LU2361044865.SGD","LU0323591593.USD","LU2896262040.SGD","LU2357305700.SGD","ELIS","LU2324357040.USD","IE00BKPKM429.USD","IE0001KFT4U8.USD","LLYX","MHIP","LU0471298777.SGD","VHT","IE00BWXC8680.SGD","IE00B7KXQ091.USD","IE00B4JS1V06.HKD","LU1623119135.USD","NVOX","LU0823434740.USD","MEDI","LU2756315318.SGD","SG9999014906.USD","MEDX","BK4534","LU1548497426.USD","BK4533","IE00BK4W5M84.HKD","BK4516","NVOH","LU2108987350.USD","LU2456880835.USD","IE0005OL40V9.USD","SGXZ57979304.SGD","SGXZ81514606.USD","IE00B775H168.HKD","LU1291159041.SGD","IE00BJJMRZ35.SGD","IE00BJJMRX11.SGD","LU1720051017.SGD","LU0106261372.USD","IE0009355771.USD","LU0466842654.USD","LU0823434583.USD","LU0174119429.USD","LU2746668974.SGD","IXJ","LU2089284900.SGD","SG9999018865.SGD","LLYZ","SG9999014914.USD","LU1551013425.SGD","SG9999018857.SGD","LU1979441026.SGD","SG9999013999.USD","LU1366192091.USD","SG9999014880.SGD","LU0289739699.SGD","LU1691799644.USD","LU2552382215.SGD","IE0004445239.USD","SG9999015952.SGD","BK4007","LU2168564149.EUR","LU2236285917.USD","LU0122379950.USD","RXL","LU0061475181.USD","LU0787776722.HKD","LU0882574139.USD","ELIL","OZEM","SG9999001176.SGD","SG9999015945.SGD","LU0256863811.USD","LU0114720955.EUR","LU0385154629.USD","LU0094547139.USD","LU0708995401.HKD","LU2089283258.USD","SG9999017495.SGD","LU2265009873.SGD","PPH","IE00BKDWB100.SGD","IE00BJT1NW94.SGD","LU2461242641.AUD","LU1720051108.HKD","SG9999001176.USD","IE00BJJMRY28.SGD","LU1868837136.USD","BK4581","LU0354030438.USD","LU1093756325.SGD","SGXZ31699556.SGD","LU0203201768.USD","LU1868836757.USD","LU0640476718.USD","LU2271345857.HKD","SG9999014898.SGD","LU0964807845.USD","LU0354030511.USD","LU1804176565.USD","SGXZ99366536.SGD","IE00BJLML261.HKD","LU0353189763.USD","LU2237443622.USD","LU2213496289.HKD","GB00BDT5M118.USD","FHLC","LU0198837287.USD","LU1069344957.HKD","LU0672654240.SGD","LU1323610961.USD","LU2106854487.HKD","LU2552382058.USD","IE00BKVL7J92.USD","LU0345770993.USD","LU2023250504.SGD","LU2491050154.USD","LU2746668461.USD","LU2237443382.USD","LU2756315664.SGD","IE0002141913.USD","IE00BN29S564.USD","LU0079474960.USD","LU2750360997.AUD","LU1093756168.USD","LU0943347566.SGD","LU1868836914.USD","LU0353189680.USD","LU1868837300.USD","LU2028103732.USD","LU0109391861.USD","LU0823416689.USD","LU0238689110.USD","LU0316494557.USD","LU1868836591.USD","LU1988902786.USD","LU0820561818.USD","THNR","LU0266013472.USD","LU0097036916.USD","LU1064131342.USD","GDOC","LU0225283273.USD","LU1280957306.USD","LU2237443465.HKD","LU0203202063.USD","LU0256863902.USD","LU2361045086.USD","IE00BFTCPJ56.SGD","LU1551013342.USD","LU2750360641.GBP","LU2264538146.SGD","NVOC","IE00B2B36J28.USD","BK4532","IE00B4R5TH58.HKD","IE0004445015.USD","LU1145028129.USD","LU1814569148.SGD","LU2087625088.SGD","LU2168564065.EUR","LU2361044949.HKD","LU0471298694.HKD","TRUH","LU2462157665.USD","LU2471134879.HKD","LU1917777945.USD","LU2552382132.HKD","LU0820561909.HKD","LU1023059063.AUD","LU2112291526.USD","LU2211815571.USD","LU2089984988.USD","SG9999015986.USD","LU2462591350.SGD","IE00B1BXHZ80.USD","LU0058720904.USD","LU0820562030.AUD","LU2491049909.HKD","IE00BFSS8Q28.SGD","LU0689472784.USD","AGNG","LU0158827948.USD","LU1712237335.SGD","LU0096364046.USD","BK4588","LU0417517546.SGD","LU0882574055.USD","LU2237443895.HKD","LU1267930730.SGD","LU2468319806.SGD","LU0786609619.USD","LU0006306889.USD","LU2168564222.USD","LU0210536198.USD","LU2237443978.SGD","LU0234572021.USD","LU2471134796.USD","LU2111349929.HKD","LU0345770308.USD","LU1057294990.SGD","IE00BK4W5L77.USD","LU0456855351.SGD","LU2237438978.USD","LU1974910355.USD","LU2471134952.CNY","LU2471134523.USD","LLY","NVO","BK4585","HRTS","LU2360106947.USD","LU0683600562.USD","JDOC","LU2023251221.USD","LU1232071149.USD","LU2168563687.JPY","LU0320765059.SGD","LU2168564495.EUR","LU0109394709.USD","LU2491050071.SGD","IE00BFSS7M15.SGD","IE00BZ1G4Q59.USD","LU1983299246.USD","LU2237443549.SGD","LU2602419157.SGD","WDNA","LU0320765992.SGD","LU0158827781.USD","BK4599","LU0154236417.USD","CURE","TMED","PJP","LU2417539215.USD","SG9999015978.USD","LU0432979614.USD","LLII","LU1035775433.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}